ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,961 | -20.5% | 987,916 | -0.8% | 0.01% | -20.0% |
| Q2 2023 | $3,724 | +0.2% | 996,275 | -10.3% | 0.02% | -6.2% |
| Q1 2023 | $3,718 | -10.9% | 1,110,715 | +27.9% | 0.02% | -23.8% |
| Q4 2022 | $4,174 | -99.9% | 868,250 | +5.1% | 0.02% | -19.2% |
| Q3 2022 | $4,696,000 | -7.4% | 825,763 | +15.6% | 0.03% | 0.0% |
| Q2 2022 | $5,072,000 | -17.6% | 714,422 | -16.2% | 0.03% | +4.0% |
| Q1 2022 | $6,152,000 | +153.5% | 852,576 | +213.1% | 0.02% | +177.8% |
| Q4 2021 | $2,427,000 | +128.5% | 272,261 | +797.2% | 0.01% | +125.0% |
| Q3 2021 | $1,062,000 | +46.7% | 30,345 | -10.0% | 0.00% | +33.3% |
| Q2 2021 | $724,000 | – | 33,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,637,331 | $57,405,000 | 37.04% |
| Bain Capital Life Sciences Investors, LLC | 3,700,000 | $129,722,000 | 8.05% |
| Cormorant Asset Management, LP | 4,928,756 | $172,802,000 | 7.02% |
| RA Capital Management | 5,427,655 | $190,294,000 | 2.64% |
| CM Management, LLC | 100,000 | $3,506,000 | 2.62% |
| Ghost Tree Capital, LLC | 150,000 | $5,259,000 | 1.54% |
| ORACLE INVESTMENT MANAGEMENT INC | 309,126 | $10,838,000 | 1.35% |
| Perceptive Advisors | 2,259,224 | $79,208,000 | 1.15% |
| Omega Fund Management, LLC | 164,577 | $5,770,000 | 0.65% |
| Monashee Investment Management LLC | 100,000 | $3,506,000 | 0.65% |